Amicus again slows migalastat's NDA timeline

Amicus Therapeutics Inc. (NASDAQ:FOLD) shed $2.29 (28%) to $6.03 in early after-hours trading Monday after it revealed a new timeline for its planned NDA submission

Read the full 255 word article

User Sign In